Navigation Links
ShangPharma Announces First Quarter 2012 Results
Date:5/17/2012

subsidies and the related costs were reclassified to other operating income/expense since the third quarter of 2011 as a result of an accounting policy change to better reflect the nature of such transactions.
The change is accounting policy was not retroactively applied due to immateriality.SHANGPHARMA CORPORATIONRECONCILIATION OF UNAUDITED GAAP TO NON-GAAP FINANCIAL DATA(in thousands of U.S. dollars, except for ADS(2) data and per ADS data)Three months endedMarch 31,2011

2012

%GAAP gross profit8,000

9,295

16.2%GAAP gross margin32.3%

30.2%Adjustments:Share-based compensation

598

274

-54.2%Non-GAAP gross profit8,598

9,569

11.3%Non-GAAP gross margin34.7%

31.1%GAAP operating expenses(5,522)

(7,681)

39.1%Adjustments:Share-based compensation

771

1,090

41.4%Non-GAAP operating expenses(4,751)

(6,591)

38.7%GAAP profit from operations2,478

1,614

-34.9%GAAP operating margin10.0%

5.2%Adjustments:Share-based compensation

1,369

1,364

-0.4%Non-GAAP profit from operations3,847

2,978

-22.6%Non-GAAP operating margin15.5%

9.7%GAAP net income3,012

1,733

-42.5%GAAP net margin12.2%

5.6%Adjustments:Share-based compensation

1,369

1,364

-0.4%Non-GAAP net income4,381

3,097

-29.3%Non-GAAP net margin 17.7%

10.1%GAAP net income per ADS, diluted :0.16

0.09

-43.8%Adjustments:Share-based compensation

0.07

0.08Non-GAAP net income per ADS, diluted:0.23

0.17

-26.1%Weighted average ADS outstanding - basic (Non-GAAP)18,644,444

18,525,549Weighted average ADS outstanding - diluted (Non-GAAP)18,947,692

18,532,976(2)  Assumes all outstanding ordinary shares are represented by ADSs. Each A
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. ShangPharma to Report First Quarter 2012 Financial Results on May 17, 2012
2. ShangPharma Corporation Files 2011 Annual Report on Form 20-F
3. ShangPharma to Report Fourth Quarter and Full Year 2011 Financial Results on March 13, 2012
4. ShangPharma to Present at Cowens 32nd Annual Health Care Conference
5. ShangPharma Announces Milestone Achievement in Research Partnership with Hengrui
6. ShangPharma Announces Opening of New Facility to Support Lillys Pipeline
7. ShangPharma to Attend Two Upcoming Investor Conferences
8. ShangPharma Announces Third Quarter 2011 Results
9. ShangPharma Purchases Shanghai In-vivo Drug Research Facility from Charles River
10. ShangPharma Corporation Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting
11. ShangPharma Corporation Announces Resignation of a Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Ill. , May 4, 2015 RadiologyAuction will ... with live video and product demonstrations at the end ... imaging equipment such as Kodak and Fuji Cr,s, Agfa ... auctioned at the first event. Various imaging equipment will ... www.RadiologyAuction.com . After years of buying and ...
(Date:5/4/2015)... , May 4, 2015 PharmaEngine, Inc. ... Pharmaceuticals, Inc. (NASDAQ: MACK ) with its ... ) jointly announced that Baxter has submitted a ... Agency (EMA) for MM-398 (irinotecan liposome injection), also ... of the pancreas who have been previously treated ...
(Date:5/4/2015)... Pa. , May 4, 2015  Makindus, Inc. ... today that the European Medicines Agency (EMA) has granted ... the treatment of Stargardt,s Disease. "We are ... MI-100 to treat Stargardt,s disease in place for ... development program in the United States ...
Breaking Medicine Technology:RadiologyAuction Announces Event Starting On May 5th 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2
... , WALTHAM, Mass., Nov. 17 Decision Resources, one ... and healthcare issues, finds that sales of agents to treat ... decade, increasing from $360 million in 2008 to $450 million ... the United Kingdom and Japan. , The new Pharmacor report ...
... 16 Symmetry Medical Inc. (NYSE: SMA ), a ... and other medical markets, announced today that Brian S. Moore, President ... and Chief Financial Officer, are scheduled to present at the 21st ... New York City on Tuesday, December 1, 2009 at 12:30 p.m. ...
Cached Medicine Technology:Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing From $360 Million in 2008 to $450 Million in 2018 2Symmetry Medical to Present at 21st Annual Piper Jaffray Health Care Conference 2
(Date:5/4/2015)... (PRWEB) May 04, 2015 Malibu ... oral antiseptic breath spray. KissSafe™ is the first ... a safer experience while adding fresh breath appeal. ... and effectively kills germs in the mouth and ... also contains ingredients that possess additional wellness benefits. ...
(Date:5/4/2015)... Milton Hershey School® has named J. Anthony Graves, ... recognizing his commitment to pediatric cancer research and the ... students. , “Dr. Graves is a tremendous example of ... a top-notch education, a nurturing environment, and the opportunity ... ’85, president of MHS. “He is applying the values ...
(Date:5/4/2015)... Johnson & Wales University (JWU) held a groundbreaking ceremony ... on Wednesday, April 22. , Johnson & Wales becomes the ... the re-alignment of Interstate-195. JWU’s new academic building, which will ... in Providence, is scheduled to be completed in July 2016. ... university purchased in 2012. , “It has long been our ...
(Date:5/4/2015)... The opportunity for children to dream of a ... forces behind The Fairy Godmother Next Door, a new children’s ... Stark. , The inspiration for the enchanting story of a ... Stark’s desire to be a fairy godmother. , “My wish ... my neighbors’ children since they were born. We discuss fairies ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Now in ... IPC clinical leaders who have made outstanding contributions to ... they serve, both in acute and post-acute care settings. ... Year, Post-Acute Provider of the Year, Advanced Practice Clinician ... Specialist Provider of the Year. Recipients are selected by ...
Breaking Medicine News(10 mins):Health News:80 Million Germs from Kissing - Introducing KissSafe™ 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3
... NEW YORK, June 25 International superstar Beyonce will perform ... to benefit the Charles & Phyllis Newman Foundation and the ... the most widely recognized and highly respected women in pop ... album I Am . . . Sasha Fierce ...
... , , Company,s Behavioral Health Grants Now ... ValueOptions(R), Inc., of Norfolk, Virginia, the behavioral health organization ... Mexico since 2005, announced today that it is awarding $3.1 ... services across the state. , , (Logo: ...
... ... Institute (SSI) announces the launch of the National ObamaCare Opt Out (NOOO!) ... not force them to join a national healthcare system, nor to purchase ... http://www.patientoptout.com , is modeled after the National Do Not Call Registry, and ...
... ... Children with Muscular Dystrophy , ... Boston, MA (PRWEB) June 25, 2009 -- In immediate response to the Muscular Dystrophy Association,s ... virus, more commonly known as the "swine flu" Camp Promise, today announced its efforts to ...
... 25 According to Millennium Research Group (MRG), ... pharmacomechanical thrombectomy (PMT) procedure adoption will accelerate over ... interest in treating deep vein thrombosis (DVT). Although ... Adjunctive Catheter-Directed Thrombolysis) trial, which will compare catheter-directed ...
... Prompts Addition of Veteran Sales Executives to Premium Provider of ... June 25 MedPro Imaging, a premium provider of new ... sales executives in support of ongoing growth. MedPro, which recently ... quarter of 2009, has named Scott Wayman the zone manager ...
Cached Medicine News:Health News:ValueOptions(R) Reinvests $3.1 Million in New Mexico 2Health News:Social Security Institute Launches the National Obamacare Opt Out (NOOO!) Registry 2Health News:Social Security Institute Launches the National Obamacare Opt Out (NOOO!) Registry 3Health News:Camp Promise Rallies To Provide Massachusetts Children With Alternative To MDA Canceled Summer Camp 2Health News:Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group 2Health News:Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group 3Health News:MedPro Imaging Adds Wayman and Sanford to Growing Sales Team 2Health News:MedPro Imaging Adds Wayman and Sanford to Growing Sales Team 3
Smartepil II is a laser particularly indicated for hair-removal where it has proved to be a valid instrument, even in the treatment of darker phototypes and telangiectasias of the face and legs....
... and powerful instrument for the dermatologist, ... @308 nm - UVB) for rapid ... to treat recalcitrant plaques, it allows ... extensive lesions without irradiating the rest ...
... Smartepil LS combines its great ... of vascular lesions with the compactness ... reproduces the same vascular protocols developed ... the same time is indicated for ...
... HIPAA-secure web-based access to patient document 24 ... through the utilization of TrackDoc. Healthcare ... the original dictation at the same time, ... document, and fax to referring physicians or ...
Medicine Products: